Juniper Pharma licenses intravaginal ring platform to Daré Bioscience
Juniper Pharmaceuticals announced an exclusive worldwide license agreement with Daré Bioscience for development and commercialization of the Company's intravaginal ring technology platform, including its three preclinical IVR candidates targeting unmet needs in women's health. April 25, 2018